## §SELF — miscsubjects portable reference **Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next. **This widget:** `article_bundle` — **LLM article bundle** Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution. - **article slug:** `retatrutide-frozen-shoulder` - **contains:** body, claims, sources, voxels, provenance, question graph, constitution, llm_manifest - **how to use:** Reference block for Grok/GPT/Gemini. Section §SELF explains the system. - **read:** https://miscsubjects.com/api/articles/retatrutide-frozen-shoulder/bundle?format=markdown ### Logical proof (verify each step) 1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution 2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/retatrutide-frozen-shoulder/sources 3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol 4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow 5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex 6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map ### Related features (explains other parts of the system) - **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/retatrutide-frozen-shoulder/topology - **voxels** — Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance. · https://miscsubjects.com/api/articles/retatrutide-frozen-shoulder/voxels - **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/retatrutide-frozen-shoulder/prompts - **ingest** — Parse pasted evidence → source ledger + claims + evidence_ingest node. - **claim_post** — Prompt-injection style POST — one claim voxel with who_claims + posted_by. · https://miscsubjects.com/api/articles/retatrutide-frozen-shoulder/voxels - **llm_manifest** — Machine-readable read/write contract for external LLMs. · https://miscsubjects.com/api/articles/llm-manifest ### Full index - JSON: https://miscsubjects.com/api/articles/system-map - Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown ### §STRUCTURE This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure ### §INTEGRITY Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you. ### §GAUNTLET Every claim on this site carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted. *Not medical advice. Tier-honest. Cite claim/source ids.* --- # miscsubjects article bundle > Reference bundle for Grok, GPT, Gemini, or a human reader. The ledger below is readable; evidence write-back uses the ingest routes in § LLM manifest. ## MASTHEAD - **identity:** `retatrutide-frozen-shoulder` v2 · content_hash `948eb5f5ae976019…` · thread_head genesis · 22 DIVs - **thesis (c1):** Retatrutide produced mean 24.2% weight loss at 48 weeks on 12 mg dose in phase 2 human trial versus 2.1% placebo. - c2 [human/active] Phase 3 TRIUMPH-1 showed up to 28.3% average weight loss at 80 weeks on 12 mg retatrutide. - c3 [human/active] GLP-1RA use associated with higher incidence of adhesive capsulitis over 5 years in observational data. - c4 [human/active] Higher BMI linked to increased adhesive capsulitis risk in adults aged 20-40 in cohort study. - **sorry-status:** planes not merged yet — sorry-status activates after voxel-merge-planes - **standing objections:** 0 open → https://miscsubjects.com/api/articles/retatrutide-frozen-shoulder/discourse - **verbs:** read free · challenge/attest open · edit/move/consolidate CAS-gated with a rows:VOXEL_* key - **reads_next:** https://miscsubjects.com/a/philosophy · https://miscsubjects.com/api/articles/retatrutide-frozen-shoulder/discourse · https://miscsubjects.com/api/protocol ## Article - **slug:** `retatrutide-frozen-shoulder` - **title:** Retatrutide for Frozen Shoulder: Metabolic Load Evidence - **url:** https://miscsubjects.com/a/retatrutide-frozen-shoulder - **register:** source_ledger - **updated:** 2026-07-17T02:41:16.350Z - **tags:** peptide, matrix ## Body ## What's breaking down if you have Frozen shoulder Frozen shoulder, also called adhesive capsulitis, involves the shoulder capsule becoming inflamed and thickened. This leads to pain and progressive loss of range of motion in three stages: freezing, frozen, and thawing. The condition can last one to three years in many cases. Excess body weight is one factor studied in relation to higher risk in certain age groups. Higher BMI correlates with increased incidence in younger adults in some cohort data. No single degeneration profile fits every case, but mechanical load from body weight and metabolic factors can contribute to ongoing joint stress. ## Why Retatrutide might help you 1. You are reading about **Frozen shoulder** — what breaks down matters before any compound name. 2. **What keeps failing:** Excess body weight multiplies compressive load on spine, hips, knees, and plantar fascia. 3. **What Retatrutide is studied to do:** Studied for GLP-1/GIP/glucagon-driven weight loss — less mechanical load, not direct disc regeneration. 4. **Therefore for you:** If that layer is part of your problem, Retatrutide is discussed because it targets repair (metabolic load / body weight) — not because it masks pain. 5. **Mechanical load:** Rough rule used in spine biomechanics — each **1 lb** of body weight lost can mean on the order of **~4 lb** less compressive load through the lumbar spine (leverage through the kinetic chain). 6. **Retatrutide** is studied for meaningful weight loss (GLP-1 / incretin pathways). 7. **Chain for you:** more weight → more disc and facet load → faster degeneration and nerve irritation; Retatrutide → weight loss → less load → less ongoing breakdown. That is **load reduction**, not disc regeneration — it gives repair peptides less damage to fight. If your frozen shoulder involves excess body weight as a contributing layer, the logic chain points to reduced overall mechanical stress through weight loss. This is load reduction rather than direct shoulder capsule repair. ## How these fit together Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile. - **Retatrutide** → metabolic load / body weight ## What the evidence actually shows Human trials on retatrutide show substantial weight loss. In a phase 2 study, the 12 mg dose led to a mean 24.2% body weight reduction at 48 weeks versus 2.1% for placebo (human tier). Phase 3 data from TRIUMPH-1 reported up to 28.3% average loss at 80 weeks on 12 mg, with extensions reaching 30.3% at 104 weeks in some participants (human tier). No human trials test retatrutide specifically for frozen shoulder. One observational analysis of GLP-1 receptor agonists (class including related compounds) found higher rates of adhesive capsulitis and other shoulder issues over five years compared to non-users (human tier). Animal or rat studies specific to retatrutide and shoulder pathology are absent from available data. Anecdotal reports on forums mention peptides like BPC-157 for frozen shoulder symptoms, but retatrutide-specific user experiences focus more on general weight loss or occasional joint discomfort (anecdotal tier). ## What scientists say Researchers note that while weight loss from GLP-1 pathways might intuitively reduce joint stress, some data show paradoxical increases in shoulder conditions with these agonists. Biomechanics literature supports the general principle that each pound lost reduces spinal compressive forces by multiples through the kinetic chain (mechanistic tier). No direct statements link retatrutide to frozen shoulder repair pathways. ## What people say on Reddit Users in retatrutide communities discuss shoulder pain as a possible side effect in some cases. Others explore peptides for frozen shoulder separately, with mixed reports on BPC combinations but little direct retatrutide linkage (anecdotal tier). ## What people say on X Limited public posts tie retatrutide directly to frozen shoulder outcomes. Discussions center on weight loss results and general side effects rather than shoulder-specific benefits or harms (anecdotal tier). ## What we do not know No clinical trials examine retatrutide for adhesive capsulitis. Direct effects on shoulder capsule inflammation or fibrosis remain unstudied. Long-term impacts on musculoskeletal conditions beyond weight loss metrics are unknown. The ~4 lb load reduction rule is a general biomechanics estimate, not validated specifically for shoulder joints in retatrutide users. ## Safety and limits Human trials report gastrointestinal side effects as most common, often mild to moderate and dose-related. Heart rate increases occurred in a dose-dependent manner, peaking mid-study. No retatrutide-specific shoulder safety data exist. All use remains investigational outside approved contexts. ## Claims (4) - **c1** [human w=0.8] Retatrutide produced mean 24.2% weight loss at 48 weeks on 12 mg dose in phase 2 human trial versus 2.1% placebo. - who_claims: grok/grok-4.3 - **c2** [human w=0.8] Phase 3 TRIUMPH-1 showed up to 28.3% average weight loss at 80 weeks on 12 mg retatrutide. - who_claims: grok/grok-4.3 - **c3** [human w=0.8] GLP-1RA use associated with higher incidence of adhesive capsulitis over 5 years in observational data. - who_claims: grok/grok-4.3 - **c4** [human w=0.8] Higher BMI linked to increased adhesive capsulitis risk in adults aged 20-40 in cohort study. - who_claims: grok/grok-4.3 ## Voxel graph (4 atoms · 4 edges) - full graph: https://miscsubjects.com/api/articles/retatrutide-frozen-shoulder/voxels ## Article constitution - full: https://miscsubjects.com/api/articles/constitution ## Source ledger (0) - chain valid: yes · head: `genesis` ## Provenance (2 model passes) - chain valid: yes · head: `f7f3367e80b7c0dd` - write · grok/grok-4.3 · 2026-06-30T01:01 · hash `579799598a8a` - voxel_divide · owner · 2026-07-17T02:41 · hash `f7f3367e80b7` ## Question graph - questions: 0 · evidence ingests: 0 ## LLM manifest — how to communicate with this ledger - system map: https://miscsubjects.com/api/articles/system-map?format=markdown - topology (ranked): https://miscsubjects.com/api/articles/retatrutide-frozen-shoulder/topology - ingest: POST https://miscsubjects.com/api/protocol/ingest - claim: POST https://miscsubjects.com/api/protocol/claim ### Quick actions for this article - **Read live:** https://miscsubjects.com/api/articles/retatrutide-frozen-shoulder/topology - **Ask (API):** POST https://miscsubjects.com/api/protocol/ask `{"slug":"retatrutide-frozen-shoulder","question":"..."}` - **Ingest your findings:** POST https://miscsubjects.com/api/protocol/ingest or text `ingest retatrutide-frozen-shoulder|your evidence` - **Post one claim:** POST https://miscsubjects.com/api/protocol/claim or text `claim retatrutide-frozen-shoulder|tier|assertion` - **iMessage ask:** `retatrutide-frozen-shoulder|your question` - **System map:** https://miscsubjects.com/api/articles/system-map?format=markdown --- ## §SELF — miscsubjects portable reference **Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next. **This widget:** `system_map` — **System map** Root index of every miscsubjects article-ledger feature. Start here if you have zero context. - **article slug:** `retatrutide-frozen-shoulder` - **contains:** body, claims, sources, voxels, provenance, question graph, constitution, llm_manifest - **how to use:** Root index of every miscsubjects article-ledger feature. Start here if you have zero context. - **read:** https://miscsubjects.com/api/articles/system-map ### Logical proof (verify each step) 1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution 2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/retatrutide-frozen-shoulder/sources 3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol 4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow 5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex 6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map ### Related features (explains other parts of the system) - **constitution** — Binding rules: required article slots, claim/source rules, ontology anti-sprawl. · https://miscsubjects.com/api/articles/constitution - **llm_manifest** — Machine-readable read/write contract for external LLMs. · https://miscsubjects.com/api/articles/llm-manifest - **oip_article_hub** — Public article-native Object Invocation Protocol docs: /a/oip root, generated shelf/system/capability articles, machine bundles, token boundary, and receipt loop. · https://miscsubjects.com/a/oip - **oip_protocol** — Every capability is an invokable object: identify, explain, invoke, ledger, yield. · https://miscsubjects.com/a/oip - **bundle** — Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/retatrutide-frozen-shoulder/bundle?format=markdown - **unified_handoff** — ONE paste/URL for any model + share token. Same self-explaining pattern as article bundle, but whole build. · https://miscsubjects.com/api/handoff?format=markdown ### Full index - JSON: https://miscsubjects.com/api/articles/system-map - Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown ### §STRUCTURE This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure ### §INTEGRITY Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you. ### §GAUNTLET Every claim on this site carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted. *Not medical advice. Tier-honest. Cite claim/source ids.*